Literature DB >> 15007118

Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy.

Andres M Kanner1, Arnoldo Soto, Hilary Gross-Kanner.   

Abstract

OBJECTIVE: S: To identify the prevalence and clinical characteristics of postictal psychiatric (PPS) and cognitive (PCS) symptoms in patients with refractory partial epilepsy and to investigate whether interictal psychiatric and cognitive symptoms worsened in severity during the postictal period.
METHODS: Using a 42-item questionnaire, the authors determined the prevalence and clinical characteristics of PPS and PCS that occurred after >50% of seizures in 100 of 114 consecutive patients with refractory partial epilepsy during a 3-month period. The postictal period was defined as the 72 hours that followed a seizure. The prevalence of all interictal psychiatric and cognitive symptoms was identified and the frequency with which they worsened postictally determined.
RESULTS: A mean of 2.8 +/- 1.8 PCS (median = 3) and 5.9 +/- 5.3 PPS (median = 5) was identified, which included postictal symptoms of depression (PSD) in 43 patients, anxiety (PSA) in 45, postictal psychotic symptoms (PIP) in 7, hypomanic symptoms in 22, neurovegetative symptoms in 52, and fatigue in 37. Most patients experienced more than one type of PPS. Independently of the occurrence of PPS, 38 patients reported a worsening of interictal psychiatric and cognitive symptoms postictally. A history of depression and anxiety significantly increased the number of PSD, PSA, and PIP.
CONCLUSIONS: Postictal psychiatric symptoms are common among patients with refractory partial epilepsy, and the severity of interictal psychiatric and cognitive symptoms commonly worsens during the postictal period.

Entities:  

Mesh:

Year:  2004        PMID: 15007118     DOI: 10.1212/01.wnl.0000113763.11862.26

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Postictal psychiatric symptoms in epilepsy.

Authors:  Kimford Meador
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

Review 2.  Anxiety and epilepsy: what neurologists and epileptologists should know.

Authors:  Heidi M Munger Clary
Journal:  Curr Neurol Neurosci Rep       Date:  2014-05       Impact factor: 5.081

Review 3.  [Patients with epilepsy and anxiety disorders. Diagnosis and treatment].

Authors:  S Beyenburg; D Schmidt
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 4.  The interictal dysphoric disorder of epilepsy: a still open debate.

Authors:  Marco Mula
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

Review 5.  Transcranial magnetic stimulation for the treatment of depression in neurologic disorders.

Authors:  Felipe Fregni; Alvaro Pascual-Leone
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 6.  Management of psychiatric and neurological comorbidities in epilepsy.

Authors:  Andres M Kanner
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

Review 7.  Should adult neurologists play a role in the management of the most common psychiatric comorbidities? Practical considerations.

Authors:  Heidi M Munger Clary; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2018-11-22       Impact factor: 2.937

Review 8.  Psychiatric and behavioral comorbidities in epilepsy: A critical reappraisal.

Authors:  Anne T Berg; Hamada H Altalib; Orrin Devinsky
Journal:  Epilepsia       Date:  2017-05-02       Impact factor: 5.864

9.  Symptoms of epilepsy and organic brain dysfunctions in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from an acute psychiatric department.

Authors:  Arne E Vaaler; Gunnar Morken; Olav M Linaker; Trond Sand; Kjell A Kvistad; Geir Bråthen
Journal:  BMC Psychiatry       Date:  2009-09-30       Impact factor: 3.630

10.  Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry.

Authors:  Willem M A Verhoeven; Jos I M Egger; W Boudewijn Gunning; Martijn Bevers; Boudewijn J H B de Pont
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.